Dr John M

cardiac electrophysiologist, cyclist, learner

  • Home
  • About
    • About Me
    • About the Blog
      • General Cardiology and Internal Medicine
    • Six Reasons why I Blog
    • What’s Electrophysiology?
    • ICD/Pacemaker
    • Electrophysiology Column / Medscape
    • Contact
  • Afib
    • AFib
    • AF in Athletes
    • The best tool to treat AF
    • Know your CHADS-VASC Score
    • 3 non-warfarin anticoagulants
    • AF ablation
      • 13 things to know about AF
      • Atrial Fib Ablation -2012 Update
      • Gender-Spec results of AF ablation
    • Female gender and stroke risk in AF
    • My AF Story
  • Heart Healthy
    • Heart Disease (by DrJohnM)
    • Healthy Living
    • Exercise
    • Nutrition
    • inflammation
  • Policy
    • Policy
    • Health Care
    • Health Care Reform
  • Doctoring
    • Doctoring
    • Knowledge
    • Reflection
    • General Medicine
      • Does your cholesterol level matter?
    • General Cardiolgy – Medicine
      • What is a normal heart rate?
      • Cardiology/Internal Med
      • General Cardiology
      • Athletic heart
        • The ECG of an athlete
      • General Medicine
      • Stroke
      • Statins
  • Cycling
    • DrJohnM on Cycling
    • How I became a bike racer
    • My top 12 Likes on Cycling
    • Cyclocross
      • A CX-Primer
    • Fitness
    • Athletic heart
    • The Mysterious Athletic Heart

How important are short AF episodes?

May 25, 2017 By Dr John

A study presented at the recent Heart Rhythm Society meeting in Chicago has added more uncertainty about the significance of short-duration AF episodes.

Before I tell you about the study, I need to clarify what I mean by short-duration AF episodes, sometimes called subclinical AF (SCAF).

SCAF is AF on a monitor that is often not felt by the patient. Doctors are seeing more of this because patients are increasingly being monitored–with pacemakers, ICDs, long-term event recorders and implantable cardiac monitors. These devices can pick up minute-long or hour-long AF episodes.

In the past, AF could only be picked up when there were symptoms that prompted an office visit or the AF lasted long enough to be recorded on a standard ECG. We call this clinical AF. And, importantly, patients with this type of AF were enrolled in clinical trials that showed benefits from taking anticoagulants (warfarin and NOACs).

In 2017, there is no clinical trial evidence that treating short-duration AF (SCAF) with anticoagulants confers benefits. These studies are ongoing.

Now to the new study. It’s called the REVEAL-AF study. This Medtronic-funded study was simple. They took about 400 older patients who had no known AF but risk-factors for getting AF and stroke (high-blood pressure, diabetes, obesity, age > 65, etc) and put Medtronic-branded internal cardiac monitors in them. (The tiny and expensive monitors can be injected under the skin in minutes under local anesthetic.)

Get this:

In patients with no known history of AF, REVEAL AF researchers discovered ≥ 6-minute episodes of AF in 30% of these patients over 18 months. Over 30 months, 40% of this group had short-duration AF. Remember, these were people without known AF.

This revelation is disruptive to the status quo because that is nearly exactly the incidence of short-duration AF that we find in patients who have just suffered a stroke of unknown causes.

Three-years ago, the CRYSTAL AF study launched the widespread use of expensive internal monitors by finding short-duration AF in about 30% of older patients who had just had a stroke of unknown cause. The thinking in 2014 went–we have to look for AF in these patients who just had a stroke because if we find AF, then we can prevent another stroke by giving anticoagulant drugs.

Well, hold on.

There are problems with this thinking. First is the REVEAL AF study that I just told you about. REVEAL AF says the average old person with risk factors (millions of these people) will have short-duration AF. That’s the same incidence of those with stroke.

The second problem with the search for short-duration AF comes from a recent analysis of the ASSERT study. In the original ASSERT study, published in 2012, researchers found short-duration AF recorded in cardiac devices (pacers and ICDs) increased the odds of a stroke by 2.5-fold.

But the new look at the ASSERT study found that only AF episodes lasting ≥ 24-hours associated with stroke events. Other studies confirm these findings–namely that only longer-duration AF increases the risk of stroke.

As I concluded in my column posted on theHeart.org | Medscape Cardiology,

“The more we learn about stroke prediction, the less valuable short-duration AF looks as a surrogate marker. Perhaps we should be looking deeper—at the reasons why the atria fibrillate or other systemic/genetic factors.”

Finally, I want to copy part of a comment on my article from Dr. Paul Dorian, a thoughtful Canadian cardiologist who “warned about relentless seeking of information when we do not know how to deal with the data the screening tests provide, especially since there is likely harm from a diagnosis of SCAF ( anxiety, possible therapy adverse effects, insurability, a label of illness, cost, etc.)”

The title of my column is REVEAL AF Dampens Excitement for the Search for Short-Duration AF

JMM

The column over on theHeart.org | Medscape Cardiology has 11 references.

  • Email
  • LinkedIn
  • Facebook
  • Twitter
  • More
  • Reddit

Related posts:

  1. Top-ten 2017 Update on Atrial Fibrillation News
  2. A short take of the big stories in cardiology in 2015
  3. Is this the most important cardiology study of the last decade?
  4. Female gender and stroke risk in atrial fibrillation: Know your CHA2DS2-VASc Score

Filed Under: Atrial fibrillation, Dabigatran/Rivaroxaban/Apixaban, Doctoring Tagged With: Stroke, Stroke prevention

John Mandrola, MD

Welcome, Enjoy, Interact. john-mandrola I am a cardiac electrophysiologist practicing in Louisville KY. I am also a husband to a palliative care doctor, a father, a bike racer, and a regular columnist at theHeart.org | Medscape

My First Book is Now Available…

Email Newsletter

Search the Site

Categories

Find me on theheart.org | Medscape Cardiology

  • Electrophysiology commentary on Medscape/Cardiology

Mandrola on Medscape

  • My Medscape column on general medical matters

For patients...Educational posts

  • 13 things to know about Atrial Fibrillation — 2014
  • A new cure of AF
  • Adding a new verb to doctoring: To deprescribe is to do a lot
  • AF ablation — 2015 A Cautionary Note
  • AF Ablation in 2012–An easier journey?
  • Atrial Flutter — 15 facts you may want to know.
  • Benign PVCs: A heart rhythm doctor’s approach.
  • Caution with early Cardioversion
  • Decisions of 2 low-risk cases of PAF
  • Defining success in AF ablation in 2014
  • Four commonly asked questions on AF ablation
  • Inflammation and AF — Get off the gas
  • Ten things to expect after AF ablation
  • The medical decsion as a gamble
  • The most important verb in our health crisis
  • Wellness Requires Ownership

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.